Tags

Type your tag names separated by a space and hit enter

Characteristics of the new progestogens in combination oral contraceptives.
Contraception. 1991 Jul; 44(1):1-10.C

Abstract

This review details the characteristic features of three new progestogens which soon will be available in low-dose combination oral contraceptive agents in the United States. Available data suggest that desogestrel, gestodene, and norgestimate are extremely potent progestogens with few androgenic side effects. The smaller changes in lipids induced by these progestogens seem to confer some advantage to the use of preparations containing one of these agents. Whether this advantage is also present clinically remains to be determined.

Links

Publisher Full Text

Authors+Show Affiliations

Rebar RW
University of Cincinnati Medical Center, Department of Obstetrics and Gynecology, Ohio 45267-0526.
Zeserson K
No affiliation info available

MeSH

Blood CoagulationCarbohydrate MetabolismContraceptives, Oral, CombinedDesogestrelHumansLipid MetabolismNorgestrelNorpregnenesProgesterone Congeners

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

1832625

Citation

Rebar, R W., and K Zeserson. "Characteristics of the New Progestogens in Combination Oral Contraceptives." Contraception, vol. 44, no. 1, 1991, pp. 1-10.
Rebar RW, Zeserson K. Characteristics of the new progestogens in combination oral contraceptives. Contraception. 1991;44(1):1-10.
Rebar, R. W., & Zeserson, K. (1991). Characteristics of the new progestogens in combination oral contraceptives. Contraception, 44(1), 1-10.
Rebar RW, Zeserson K. Characteristics of the New Progestogens in Combination Oral Contraceptives. Contraception. 1991;44(1):1-10. PubMed PMID: 1832625.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Characteristics of the new progestogens in combination oral contraceptives. AU - Rebar,R W, AU - Zeserson,K, PY - 1991/7/1/pubmed PY - 1991/7/1/medline PY - 1991/7/1/entrez KW - Biology KW - Blood Coagulation Effects KW - Carbohydrate Metabolic Effects KW - Contraception KW - Contraceptive Agents, Female--pharmacodynamics KW - Contraceptive Agents, Progestin--pharmacodynamics KW - Contraceptive Agents--pharmacodynamics KW - Contraceptive Methods--pharmacodynamics KW - Contraceptive Mode Of Action KW - Desogestrel--pharmacodynamics KW - Family Planning KW - Gestodene--pharmacodynamics KW - Hematological Effects KW - Hemic System KW - Lipid Metabolic Effects KW - Lipids KW - Metabolic Effects KW - Norgestimate--pharmacodynamics KW - Oral Contraceptives, Combined--pharmacodynamics KW - Oral Contraceptives--pharmacodynamics KW - Ovulation Suppression KW - Physiology SP - 1 EP - 10 JF - Contraception JO - Contraception VL - 44 IS - 1 N2 - This review details the characteristic features of three new progestogens which soon will be available in low-dose combination oral contraceptive agents in the United States. Available data suggest that desogestrel, gestodene, and norgestimate are extremely potent progestogens with few androgenic side effects. The smaller changes in lipids induced by these progestogens seem to confer some advantage to the use of preparations containing one of these agents. Whether this advantage is also present clinically remains to be determined. SN - 0010-7824 UR - https://www.unboundmedicine.com/medline/citation/1832625/Characteristics_of_the_new_progestogens_in_combination_oral_contraceptives_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0010-7824(91)90101-K DB - PRIME DP - Unbound Medicine ER -